IL17A and psoriasis: Anti-psoriatic therapies include topical treatment with glucocorticoids or retinoids and systemic treatment such as methotrexate, cyclosporine, corticosteroids, fumarate and several biologics targeting the key players in psoriasis (TNFα, IL-17 and IL-23) or their signaling pathways.